Peter Dove

2.2k total citations
14 papers, 150 citations indexed

About

Peter Dove is a scholar working on Molecular Biology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Peter Dove has authored 14 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 3 papers in Psychiatry and Mental health. Recurrent topics in Peter Dove's work include Nitric Oxide and Endothelin Effects (5 papers), Ion channel regulation and function (2 papers) and Epilepsy research and treatment (2 papers). Peter Dove is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), Ion channel regulation and function (2 papers) and Epilepsy research and treatment (2 papers). Peter Dove collaborates with scholars based in United States, Canada and Slovenia. Peter Dove's co-authors include John S. Andrews, Frank Porreca, Shawn P. Maddaford, Suman Rakhit, Jailall Ramnauth, Gabriela Mladenova, András Sándor, Milena De Felice, Marvin E. Rosenthale and David K.H. Lee and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Peter Dove

12 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Dove United States 8 60 57 35 25 21 14 150
Graham C. Bloomfield Switzerland 5 65 1.1× 32 0.6× 84 2.4× 8 0.3× 6 0.3× 6 235
Jonathan D. Rosen United States 11 125 2.1× 21 0.4× 117 3.3× 58 2.3× 28 1.3× 31 297
Syed Jawad Ali Shah Pakistan 13 161 2.7× 34 0.6× 164 4.7× 46 1.8× 12 0.6× 35 379
Neel K. Anand Switzerland 4 142 2.4× 17 0.3× 50 1.4× 17 0.7× 16 0.8× 5 211
Rainer M. Lüönd Switzerland 6 27 0.5× 126 2.2× 73 2.1× 57 2.3× 7 0.3× 8 249
Todd R. Elworthy United States 12 233 3.9× 24 0.4× 120 3.4× 40 1.6× 29 1.4× 16 361
Geoff T. Halvorsen United States 8 77 1.3× 71 1.2× 77 2.2× 20 0.8× 5 0.2× 8 207
Izumi Nomura Japan 10 263 4.4× 46 0.8× 82 2.3× 55 2.2× 18 0.9× 18 389
Eric P. Arnold United States 8 157 2.6× 29 0.5× 155 4.4× 32 1.3× 7 0.3× 12 263

Countries citing papers authored by Peter Dove

Since Specialization
Citations

This map shows the geographic impact of Peter Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dove more than expected).

Fields of papers citing papers by Peter Dove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dove. The network helps show where Peter Dove may publish in the future.

Co-authorship network of co-authors of Peter Dove

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Dove. A scholar is included among the top collaborators of Peter Dove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Dove. Peter Dove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Zezhou, Peter Dove, Karen Dodge, et al.. (2019). Abstract 3854: Preclinical characterization of a novel non-cyclic dinucleotide small molecule STING agonist with potent antitumor activity in mice. Cancer Research. 79(13_Supplement). 3854–3854. 8 indexed citations
2.
Dove, Peter, Shane Climie, Zezhou Wang, et al.. (2015). FV-009 candidate drug: Novel and selective P/Q-type Ca2+ and voltage-gated Na+ ion channel modulation for epilepsy and pain. Epilepsy & Behavior. 46. 57–57. 1 indexed citations
3.
Dove, Peter, Aisha Shamas‐Din, Alex Nachman, et al.. (2015). FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing. Cell Death and Disease. 6(7). e1815–e1815. 2 indexed citations
4.
Dove, Peter, Shane Climie, Zezhou Wang, et al.. (2015). FV-082: A safer orally active broad-spectrum antiepileptic drug candidate. Epilepsy & Behavior. 46. 57–58. 1 indexed citations
5.
Wang, Zezhou, Peter Dove, Aisha Shamas‐Din, et al.. (2015). The Highly Potent Bromodomain (BRD) Inhibitor FV-281 Displays Preclinical Efficacy in Acute Myeloid Leukemia (AML). Blood. 126(23). 1364–1364.
6.
Ramnauth, Jailall, Shawn P. Maddaford, Peter Dove, et al.. (2012). Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS). Bioorganic & Medicinal Chemistry Letters. 22(7). 2510–2513. 8 indexed citations
7.
8.
9.
Ramnauth, Jailall, Shawn P. Maddaford, Peter Dove, et al.. (2011). Design, Synthesis, and Biological Evaluation of 3,4-Dihydroquinolin-2(1H)-one and 1,2,3,4-Tetrahydroquinoline-Based Selective Human Neuronal Nitric Oxide Synthase (nNOS) Inhibitors. Journal of Medicinal Chemistry. 54(15). 5562–5575. 30 indexed citations
10.
11.
Dove, Peter. (2005). Genetic Polymorphisms in Milk Protein Genes and their Impact on Milk Composition. Kluwer Academic Publishers eBooks. 480. 225–230. 11 indexed citations
12.
Nielsen, Susan, et al.. (1987). Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity.. PubMed. 13(5). 297–304. 1 indexed citations
13.
Dove, Peter, et al.. (1982). [Anti-arrhythmic drugs: side-effects and toxicity (digitalis, amiodarone and beta-blocking agents not included)].. PubMed. 37(3). 299–314. 1 indexed citations
14.
Dove, Peter, et al.. (1977). A profile of the gastrointestinal toxicity of aspirin, indomethacin, oxaprozin, phenylbutazone, and fentiazac in arthritic and Lewis normal rats. Toxicology and Applied Pharmacology. 42(1). 75–83. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graham C. Bloomfield Breakdown of academic impact, for papers by Jonathan D. Rosen Breakdown of academic impact, for papers by Syed Jawad Ali Shah Breakdown of academic impact, for papers by Neel K. Anand Breakdown of academic impact, for papers by Rainer M. Lüönd Breakdown of academic impact, for papers by Todd R. Elworthy Breakdown of academic impact, for papers by Geoff T. Halvorsen Breakdown of academic impact, for papers by Izumi Nomura Breakdown of academic impact, for papers by Eric P. Arnold
Rankless by CCL
2026